Related Experiment Videos
Inhibition of the activation of Hageman factor (factor XII) by aprotinin (Trasylol)
M T Laurel1, O D Ratnoff, B Everson
1Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH 44106.
The Journal of Laboratory and Clinical Medicine
|May 1, 1992
Abstract:
Aprotinin (Trasylol; Bayer AG, Leverkusen, Germany), a protease inhibitor resembling or identical with Kunitz' pancreatic trypsin inhibitor, is said to have anticoagulant properties, but these are not clearly defined. The present study provides evidence that one action of aprotinin is inhibition of the activation of Hageman factor (factor XII).